Reprogramming human B cells with custom heavy chain antibodies.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
30 Jun 2023
30 Jun 2023
Historique:
pubmed:
10
7
2023
medline:
10
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
We describe a genome editing strategy to reprogram the immunoglobulin heavy chain (IgH) locus of human B cells to express custom molecules that respond to immunization. These heavy chain antibodies (HCAbs) comprise a custom antigen-recognition domain linked to an Fc domain derived from the IgH locus and can be differentially spliced to express either B cell receptor (BCR) or secreted antibody isoforms. The HCAb editing platform is highly flexible, supporting antigen-binding domains based on both antibody and non-antibody components, and also allowing alterations in the Fc domain. Using HIV Env protein as a model antigen, we show that B cells edited to express anti-Env HCAbs support the regulated expression of both BCRs and antibodies, and respond to Env antigen in a tonsil organoid model of immunization. In this way, human B cells can be reprogrammed to produce customized therapeutic molecules with the potential for
Identifiants
pubmed: 37425794
doi: 10.1101/2023.06.28.546944
pmc: PMC10327003
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI164561
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL156274
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014089
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164556
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH130178
Pays : United States